Published in Neuropsychopharmacology on June 25, 2003
Serotonin transporters: implications for antidepressant drug development. AAPS J (2005) 1.02
Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. Psychopharmacology (Berl) (2005) 0.88
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Neuropsychopharmacology (2008) 0.88
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance. Curr Neuropharmacol (2012) 0.83
Early-life stress induces persistent alterations in 5-HT1A receptor and serotonin transporter mRNA expression in the adult rat brain. Front Mol Neurosci (2014) 0.81
Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum. Neurosci Lett (2009) 0.80
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Leptin: a potential novel antidepressant. Proc Natl Acad Sci U S A (2006) 2.15
Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology (2007) 1.61
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol (2004) 1.42
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology (2004) 1.38
Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl) (2008) 1.24
Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav (2002) 1.15
Chronic cold stress sensitizes brain noradrenergic reactivity and noradrenergic facilitation of the HPA stress response in Wistar Kyoto rats. Brain Res (2003) 1.14
Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. J Neurosci Methods (2005) 1.14
Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology (2002) 1.12
Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test. Neuropsychopharmacology (2006) 1.08
What should animal models of depression model? Neurosci Biobehav Rev (2005) 1.06
Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci (2002) 1.06
Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One (2012) 1.03
Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.99
Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol (2000) 0.98
Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology (2003) 0.96
Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.96
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. Biol Psychiatry (2011) 0.96
A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment. Int J Neuropsychopharmacol (2010) 0.95
Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology (2008) 0.95
Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology (2007) 0.95
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem (2007) 0.95
Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development. J Clin Psychopharmacol (2006) 0.93
Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol Psychiatry (2004) 0.93
Comparison of the effects of estradiol and progesterone on serotonergic function. Biol Psychiatry (2012) 0.92
A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry (2005) 0.91
Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology (2002) 0.91
Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements. J Affect Disord (2010) 0.90
Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain. Psychoneuroendocrinology (2011) 0.90
Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology (2008) 0.88
Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol (2008) 0.87
5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. Int J Neuropsychopharmacol (2011) 0.86
Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity. Neuropharmacology (2012) 0.86
A novel role for brain interleukin-6: facilitation of cognitive flexibility in rat orbitofrontal cortex. J Neurosci (2014) 0.86
One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety? Neuropeptides (2005) 0.86
Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology (2012) 0.85
Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognition. Neuropsychopharmacology (2012) 0.84
Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment. J Neurochem (2004) 0.84
Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. J Neurochem (2003) 0.82
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants. Neuropsychopharmacology (2002) 0.82
Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway. Psychopharmacology (Berl) (2015) 0.81
[(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic Clin Pharmacol Toxicol (2007) 0.81
Exogenous prenatal corticosterone exposure mimics the effects of prenatal stress on adult brain stress response systems and fear extinction behavior. Psychoneuroendocrinology (2013) 0.81
Effects of milnacipran on cognitive flexibility following chronic stress in rats. Eur J Pharmacol (2013) 0.80
The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress. Behav Brain Res (2009) 0.80
Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition. Int J Neuropsychopharmacol (2007) 0.80
Administration of the galanin antagonist M40 into lateral septum attenuates shock probe defensive burying behavior in rats. Neuropeptides (2005) 0.79
A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease. Behav Brain Res (2011) 0.79
Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Res (2002) 0.79
A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. Int J Neuropsychopharmacol (2004) 0.78
Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants. J Pharmacol Exp Ther (2012) 0.78
Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. Synapse (2006) 0.78
Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats. Neuroendocrinology (2015) 0.77
Novel cage stress alters remote contextual fear extinction and regional T2 magnetic resonance relaxation times in TASTPM mice overexpressing amyloid. J Alzheimers Dis (2010) 0.77
Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. Biol Psychiatry (2006) 0.77
Corticotropin-releasing factor receptor 1 activation during exposure to novelty stress protects against Alzheimer's disease-like cognitive decline in AβPP/PS1 mice. J Alzheimers Dis (2013) 0.76
Influence of acute or chronic administration of ovarian hormones on the effects of desipramine in the forced swim test in female rats. Psychopharmacology (Berl) (2014) 0.75
A video method for the evaluation of antidepressant clinical and behavioural actions. Int J Neuropsychopharmacol (2005) 0.75
The long-term impact of stress on brain function: from adaptation to mental diseases. Neurosci Biobehav Rev (2008) 0.75
The International Journal of Neuropsychopharmacology. Int J Neuropsychopharmacol (1998) 0.75
The componential approach enhances the effectiveness of 2-week trials for new antidepressants. J Clin Psychopharmacol (2011) 0.75
Preclinical models of schizophrenia. Int J Neuropsychopharmacol (2013) 0.75
Evidence for shortening the duration of clinical trials of antidepressants and a proposed paradigm for such studies. J Clin Psychopharmacol (2015) 0.75